INCY
Income statement / Annual
Last year (2025), Incyte Corp.'s total revenue was $5.14 B,
an increase of 21.22% from the previous year.
In 2025, Incyte Corp.'s net income was $1.29 B.
See Incyte Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$5.14 B |
$4.24 B |
$3.70 B |
$3.39 B |
$2.99 B |
$2.67 B |
$2.16 B |
$1.88 B |
$1.54 B |
$1.11 B |
| Cost of Revenue |
$438.72 M
|
$377.72 M
|
$315.15 M
|
$253.35 M
|
$187.34 M
|
$161.64 M
|
$147.28 M
|
$127.59 M
|
$110.16 M
|
$104.01 M
|
| Gross Profit |
$4.70 B
|
$3.86 B
|
$3.38 B
|
$3.14 B
|
$2.80 B
|
$2.51 B
|
$2.01 B
|
$1.75 B
|
$1.43 B
|
$1.00 B
|
| Gross Profit Ratio |
0.91
|
0.91
|
0.91
|
0.93
|
0.94
|
0.94
|
0.93
|
0.93
|
0.93
|
0.91
|
| Research and Development Expenses |
$1.98 B
|
$2.61 B
|
$1.63 B
|
$1.59 B
|
$1.46 B
|
$2.22 B
|
$1.15 B
|
$1.20 B
|
$1.33 B
|
$581.86 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.38 B
|
$1.18 B
|
$1.10 B
|
$955.79 M
|
$703.22 M
|
$516.90 M
|
$435.68 M
|
$400.94 M
|
$335.61 M
|
$255.83 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$12.52 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$3.36 B
|
$3.78 B
|
$2.73 B
|
$2.54 B
|
$2.16 B
|
$2.75 B
|
$1.59 B
|
$1.60 B
|
$1.66 B
|
$837.69 M
|
| Cost And Expenses |
$3.80 B
|
$4.16 B
|
$3.04 B
|
$2.80 B
|
$2.35 B
|
$2.91 B
|
$1.74 B
|
$1.73 B
|
$1.77 B
|
$941.70 M
|
| Interest Income |
$105.60 M
|
$128.71 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4.61 M
|
| Interest Expense |
$2.43 M
|
$2.28 M
|
$2.55 M
|
$2.67 M
|
$1.91 M
|
$2.17 M
|
$1.86 M
|
$1.54 M
|
$6.90 M
|
$38.75 M
|
| Depreciation & Amortization |
$93.29 M
|
$89.25 M
|
$82.66 M
|
$67.86 M
|
$57.84 M
|
$51.81 M
|
$54.53 M
|
$54.97 M
|
$52.18 M
|
$58.43 M
|
| EBITDA |
$1.76 B |
$408.16 M |
$919.43 M |
$599.64 M |
$630.20 M |
-$178.24 M |
$543.18 M |
$171.86 M |
-$253.21 M |
$204.57 M |
| EBITDA Ratio |
0.34
|
0.1
|
0.25
|
0.18
|
0.21
|
-0.07
|
0.25
|
0.09
|
-0.16
|
0.19
|
| Operating Income Ratio |
0.26
|
0.02
|
0.18
|
0.18
|
0.21
|
-0.09
|
0.2
|
0.08
|
-0.15
|
0.15
|
| Total Other Income/Expenses Net |
$321.70 M
|
$236.49 M
|
$182.44 M
|
-$70.45 M
|
-$67.09 M
|
$8.07 M
|
$65.10 M
|
-$40.05 M
|
-$76.61 M
|
-$56.62 M
|
| Income Before Tax |
$1.66 B
|
$316.63 M
|
$834.22 M
|
$529.12 M
|
$570.44 M
|
-$232.22 M
|
$486.79 M
|
$115.35 M
|
-$312.29 M
|
$107.40 M
|
| Income Before Tax Ratio |
0.32
|
0.07
|
0.23
|
0.16
|
0.19
|
-0.09
|
0.23
|
0.06
|
-0.2
|
0.1
|
| Income Tax Expense |
$377.80 M
|
$284.02 M
|
$236.62 M
|
$188.46 M
|
-$378.14 M
|
$63.48 M
|
$39.89 M
|
$5.85 M
|
$852.00 K
|
$3.18 M
|
| Net Income |
$1.29 B
|
$32.62 M
|
$597.60 M
|
$340.66 M
|
$948.58 M
|
-$295.70 M
|
$446.91 M
|
$109.49 M
|
-$313.14 M
|
$104.22 M
|
| Net Income Ratio |
0.25
|
0.01
|
0.16
|
0.1
|
0.32
|
-0.11
|
0.21
|
0.06
|
-0.2
|
0.09
|
| EPS |
6.59 |
0.16 |
2.67 |
1.53 |
4.3 |
-1.36 |
2.08 |
0.52 |
-1.53 |
0.55 |
| EPS Diluted |
6.41 |
0.15 |
2.65 |
1.52 |
4.27 |
-1.36 |
2.05 |
0.51 |
-1.53 |
0.54 |
| Weighted Average Shares Out |
$195.20 M
|
$207.11 M
|
$223.63 M
|
$222.00 M
|
$220.43 M
|
$218.07 M
|
$214.91 M
|
$212.38 M
|
$204.58 M
|
$187.87 M
|
| Weighted Average Shares Out Diluted |
$200.70 M
|
$210.53 M
|
$225.93 M
|
$223.96 M
|
$222.07 M
|
$218.07 M
|
$217.66 M
|
$215.64 M
|
$204.58 M
|
$194.13 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
